Does IPILIMUMAB Cause Cholecystitis acute? 21 Reports in FDA Database

Q: Does IPILIMUMAB cause Cholecystitis acute?

21 reports of Cholecystitis acute have been filed with the FDA for IPILIMUMAB, representing 0.1% of all IPILIMUMAB adverse event reports.

Q: How dangerous is Cholecystitis acute from IPILIMUMAB?

Of 21 reports, 1 (4.8%) resulted in death and 18 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Cholecystitis acute have been filed in association with IPILIMUMAB (YERVOY). This represents 0.1% of all adverse event reports for IPILIMUMAB.

Reports of Cholecystitis acute with IPILIMUMAB

0.1%

of all IPILIMUMAB reports

Deaths

Hospitalizations

How Dangerous Is Cholecystitis acute From IPILIMUMAB?

Of the 21 reports, 1 (4.8%) resulted in death, 18 (85.7%) required hospitalization.

Is Cholecystitis acute Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does IPILIMUMAB Cause?

Death (3,710) Malignant neoplasm progression (3,296) Diarrhoea (2,557) Off label use (2,097) Colitis (1,988) Pyrexia (1,796) Rash (1,556) Fatigue (1,447) Intentional product use issue (1,329) Nausea (1,169)

What Other Drugs Cause Cholecystitis acute?

LENVATINIB (124) RITUXIMAB (111) YAZ (109) YASMIN (103) DEXAMETHASONE (99) METHOTREXATE (98) PEMBROLIZUMAB (94) SEMAGLUTIDE (93) ASPIRIN (84) LENALIDOMIDE (84)

Which IPILIMUMAB Alternatives Have Lower Cholecystitis acute Risk?

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE IPILIMUMAB vs IPRATROPIUM IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS IPILIMUMAB vs IPTACOPAN IPILIMUMAB vs IRBESARTAN

IPILIMUMAB Full Profile All Cholecystitis acute Reports All Drugs Causing Cholecystitis acute IPILIMUMAB Demographics